While glycosylation of the mammalian produced RON protein is probably a major factor in this selection the panel of antibodies reveals unexpected features of RON expression in cancer cells since antibodies to the bacterially produced protein proved highly active in xenograft models. This evidence concerns the gene MST1R and cancer.